[1] |
JIN R, WANG XX, LIU F, et al. Research advances in pharmacotherapy for nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2022, 38(7): 1634-1640. DOI: 10.3969/j.issn.1001-5256.2022.07.033.
靳睿, 王晓晓, 刘峰, 等. 非酒精性脂肪性肝病的药物治疗进展[J]. 临床肝胆病杂志, 2022, 38(7): 1634-1640. DOI: 10.3969/j.issn.1001-5256.2022.07.033.
|
[2] |
ESLAM M, ALKHOURI N, VAJRO P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement[J]. Lancet Gastroenterol Hepatol, 2021, 6(10): 864-873. DOI: 10.1016/S2468-1253(21)00183-7.
|
[3] |
ESLAM M, NEWSOME PN, SARIN SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement[J]. J Hepatol, 2020, 73(1): 202-209. DOI: 10.1016/j.jhep.2020.03.039.
|
[4] |
FLISIAK-JACKIEWICZ M, LEBENSZTEJN DM. Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children[J]. Clin Exp Hepatol, 2019, 5(1): 11-21. DOI: 10.5114/ceh.2019.83152.
|
[5] |
CZAJA AJ. Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease[J]. World J Gastroenterol, 2021, 27 (25): 3705-3733. DOI: 10.3748/wjg.v27.i25.3705.
|
[6] |
LEGOUX F, BELLET D, DAVIAUD C, et al. Microbial metabolites control the thymic development of mucosal-associated invariant T cells[J]. Science, 2019, 366(6464): 494-499. DOI: 10.1126/science.aaw2719.
|
[7] |
HEGDE P, WEISS E, PARADIS V, et al. Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver[J]. Nat Commun, 2018, 9(1): 2146. DOI: 10.1038/s41467-018-04450-y.
|
[8] |
LI Y, HUANG B, JIANG X, et al. Mucosalassociated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization[J]. Front Immunol, 2018, 9: 1994. DOI: 10.3389/fimmu.2018.01994.
|
[9] |
DIEDRICH T, KUMMER S, GALANTE A, et al. Characterization of the immune cell landscape of patients with NAFLD[J]. PLoS One, 2020, 15(3): e0230307. DOI: 10.1371/journal.pone.0230307.
|
[10] |
HE SL, LI SJ, LIU M, et al. Study on the diagnostic value of transient elastography, APRI and FIB-4 for liver fibrosis in children with non-alcoholic fatty liver disease[J]. Chin J Hepatol, 2022, 30(1): 81-86. DOI: 10.3760/cma.j.cn501113-20210105-00007.
何舒丽, 李双杰, 刘敏, 等. 瞬时弹性成像技术、APRI及FIB-4对儿童非酒精性脂肪性肝病肝纤维化诊断价值的研究[J]. 中华肝脏病杂志, 2022, 30(1): 81-86. DOI: 10.3760/cma.j.cn501113-20210105-00007.
|
[11] |
LIU M, ZHENG X, QIU J, et al. Diagnostic value of CAP in children with nonalcoholic fatty liver disease[J]. J Clin Res, 2021, 38(3): 343-348. DOI: 10.3969/j.issn.1671-7171.2021.03.006.
刘敏, 郑曦, 仇君, 等. CAP对儿童非酒精性脂肪性肝病的诊断价值研究[J]. 医学临床研究, 2021, 38(3): 343-348. DOI: 10.3969/j.issn.1671-7171.2021.03.006.
|
[12] |
CAROLAN E, TOBIN LM, MANGAN BA, et al. Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity[J]. J Immunol, 2015, 194(12): 5775-5780. DOI: 10.4049/jimmunol.1402945.
|
[13] |
MAGALHAES I, PINGRIS K, POITOU C, et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients[J]. J Clin Invest, 2015, 125(4): 1752-1762. DOI: 10.1172/JCI78941.
|
[14] |
van HERCK MA, WEYLER J, KWANTEN WJ, et al. The differential roles of T cells in non-alcoholic fatty liver disease and obesity[J]. Front Immunol, 2019, 10: 82. DOI: 10.3389/fimmu.2019.00082.
|
[15] |
LIU J, NAN H, BRUTKIEWICZ RR, et al. Sex discrepancy in the reduction of mucosal-associated invariant T cells caused by obesity[J]. Immun Inflamm Dis, 2021, 9(1): 299-309. DOI: 10.1002/iid3.393.
|
[16] |
BERGIN R, KINLEN D, KEDIA-MEHTA N, et al. Mucosal-associated invariant T cells are associated with insulin resistance in childhood obesity, and disrupt insulin signalling via IL-17[J]. Diabetologia, 2022, 65(6): 1012-1017. DOI: 10.1007/s00125-022-05682-w.
|
[17] |
NAIMIMOHASSES S, O'GORMAN P, WRIGHT C, et al. Differential effects of dietary versus exercise intervention on intrahepatic MAIT cells and histological features of NAFLD[J]. Nutrients, 2022, 14(11): 2198. DOI: 10.3390/nu14112198.
|
[18] |
KOAY HF, GHERARDIN NA, ENDERS A, et al. A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage[J]. Nat Immunol, 2016, 17(11): 1300-1311. DOI: 10.1038/ni.3565.
|
[19] |
ZENG F, ZHANG Y, HAN X, et al. Predicting non-alcoholic fatty liver disease progression and immune deregulations by specific gene expression patterns[J]. Front Immunol, 2020, 11: 609900. DOI: 10.3389/fimmu.2020.609900.
|